| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/10/2011 | US20110033456 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 02/10/2011 | US20110033452 Anti-Glypican 3 Antibody Having Modified Sugar Chain |
| 02/10/2011 | US20110033389 Modified antibodies for passive immunotherapy |
| 02/09/2011 | EP2281893A1 System for the expression of peptides on the bacterial surface |
| 02/09/2011 | EP2281892A2 Methods for producing polypeptides in respiratory-deficient Trichoderma cells |
| 02/09/2011 | EP2281891A2 Streptococcus antigens |
| 02/09/2011 | EP2281845A1 Stable polyvalent antibody |
| 02/09/2011 | EP2281843A1 Antibodies that immunospecifically bind to blys |
| 02/09/2011 | EP2281842A1 Antibodies that immunospecifically bind to BLyS |
| 02/09/2011 | EP2281838A1 Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein |
| 02/09/2011 | EP2281837A2 Antigen binding domains from fish |
| 02/09/2011 | EP2281835A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281834A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281833A2 Anti-bacterial vaccine compositions |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP1947111B1 Mucin glycoprotein and use thereof |
| 02/09/2011 | EP1725659B1 Natural igm antibodies and inhibitors thereof |
| 02/09/2011 | EP1680502B1 Recombinant microorganism |
| 02/09/2011 | EP1504098B2 A method for in vitro molecular evolution of protein function |
| 02/09/2011 | EP1311680B1 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor |
| 02/09/2011 | EP1280898B1 Modified es cells and es cell-specific gene |
| 02/09/2011 | EP1100929B1 Identification and functional characterization of a novel ribosomal s6 protein kinase |
| 02/09/2011 | EP0986577B1 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
| 02/09/2011 | EP0848755B2 Vegf-related protein |
| 02/09/2011 | EP0668777B2 Prostate-specific membrane antigen |
| 02/09/2011 | CN101970679A Aminotransferase and oxidoreductase nucleic acids and polypeptides and methods of using |
| 02/09/2011 | CN101970678A Biological active proteins having increased in vivo and/or vitro stability |
| 02/09/2011 | CN101970639A Microorganism producing cyclic compound |
| 02/09/2011 | CN101970481A Demannosylated recombinant factor viii for the treatment of patients with hemophiila a |
| 02/09/2011 | CN101970468A Component protein pa1698 for type-iii secretion system of pseudomonas aeruginosa |
| 02/09/2011 | CN101970462A Cyclic compound and salt thereof |
| 02/09/2011 | CN101970456A Tag peptide and use thereof |
| 02/09/2011 | CN101970005A Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 02/09/2011 | CN101968487A Immune colloidal gold test paper for detecting listeria hemolysin and preparation method thereof |
| 02/09/2011 | CN101967493A Prokaryotic expression vector and application thereof |
| 02/09/2011 | CN101967492A Simple and easy solubility expression and purifying method for recombinant human amyloid polypeptide A beta 42 |
| 02/09/2011 | CN101967465A Retinol binding protein (RBP) monoclonal antibody and hybridoma cells, preparation method and application thereof |
| 02/09/2011 | CN101967192A Fusion protein of anti-CD20 antibody fragment and lidamycin (LDM) as well as preparation method and application thereof |
| 02/09/2011 | CN101967191A Preparation method of HLA-G (Human Leukocyte Antigen G) antibody and application of HLA-G antibody in medicine |
| 02/09/2011 | CN101967189A RBP4 (Retinol Binding Protein 4) monoclonal antibody and hybridoma cells thereof as well as preparation method and applications thereof |
| 02/09/2011 | CN101967182A Antimicrobial compound and preparation method and application thereof |
| 02/09/2011 | CN101613707B Method for producing glutathione by use of metabolic engineering bacteria |
| 02/09/2011 | CN101538539B Culture medium for biosynthesis of virginiamycin M |
| 02/09/2011 | CN101205530B Method for high-effectively expressing recombinant protein by employing animal cell fed-batch culture mode |
| 02/09/2011 | CN101117642B Polypeptide capable of lowering blood pressure and method for preparing same |
| 02/09/2011 | CN101086006B Composite type biological surfactant and its production method |
| 02/08/2011 | US7884198 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 02/08/2011 | US7884193 Antibodies for identification of murine fragilis extracellular domain and methods for identifying pluripotent cells |
| 02/08/2011 | US7884192 Twin-arginine translocation in Bacillus |
| 02/08/2011 | US7884191 Twin-arginine translocation in Bacillus |
| 02/08/2011 | US7884190 Recombinant dimeric and heterodimeric proteins comprising amino acids 193 to 252 of the β chain of the human C4BP protein |
| 02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 02/08/2011 | US7884078 CPG15 compounds as insulin receptor and insulin-like growth factor receptor agonists |
| 02/08/2011 | US7884054 Methods for identifying functional antibodies |
| 02/08/2011 | US7883896 for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as lung adenocarcinoma, lung carcinoma |
| 02/08/2011 | US7883895 capable of modulating exopolysaccharide production in Sphingomonas; using such nucleic acid sequences to generate bacteria that hyper-produce exopolysaccharide in slime form; produce exopolysaccharide in a form that does not increase the viscosity of a fermentation broth |
| 02/08/2011 | US7883882 Renewable chemical production from novel fatty acid feedstocks |
| 02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/08/2011 | US7883877 Compositions and methods for enhanced bacterial exopolysaccharide production |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883867 Solubilization and purification of a target protein fused to a mutant maltose-binding protein |
| 02/08/2011 | US7883866 Compositions of aminoacyl-tRNA synthetase and uses thereof |
| 02/08/2011 | US7883865 Production of cell culture product and material for use in said production |
| 02/08/2011 | US7883710 Peptide vaccines against Group A streptococci |
| 02/08/2011 | US7883706 Methods for using Streptococcus pyogenes polypeptides |
| 02/08/2011 | US7883704 Methods for inhibiting the activity of the P40 subunit of human IL-12 |
| 02/08/2011 | CA2529124C Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 02/08/2011 | CA2419822C Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 02/08/2011 | CA2386255C Transformants producing secondary metabolites modified with functional groups, and novel biosynthesis genes |
| 02/08/2011 | CA2325566C Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 02/08/2011 | CA2295849C Trichoderma reesei swollenin protein and encoding dna sequence |
| 02/08/2011 | CA2210467C Osteoprotegerin |
| 02/08/2011 | CA2199940C Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 02/08/2011 | CA2184059C Human trk receptors and neurotrophic factor inhibitors |
| 02/08/2011 | CA2164226C Methods for selectively stimulating proliferation of t cells |
| 02/03/2011 | WO2011014659A2 Dual variable domain immunoglobulins and uses thereof |
| 02/03/2011 | WO2011012254A1 Pichia pastoris as a host for the production of the ribosome-inactivating protein (rip) saporin and saporin fusion chimaeras |
| 02/03/2011 | US20110030096 AXMI-192 Family of Pesticidal Genes and Methods for Their Use |
| 02/03/2011 | US20110028700 Mutant proteins and methods for producing them |
| 02/03/2011 | US20110028691 Recombinant toxin fragments |
| 02/03/2011 | US20110028399 Citrullinated cytokines |
| 02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
| 02/03/2011 | US20110027867 Methods and compositions for the production of orthogonal tRNA-aminoacyltRNA synthetase pairs |
| 02/03/2011 | US20110027860 Gene encoding chondroitinase abc and uses therefor |
| 02/03/2011 | US20110027830 Use of an aspartic protease (ns24) signal sequence for heterologous protein expression |
| 02/03/2011 | US20110027829 Methods and Compositions |
| 02/03/2011 | US20110027366 Skin equivalent culture |
| 02/03/2011 | US20110027321 Chlamydia Vaccine Comprising HtrA Polypeptides |
| 02/03/2011 | US20110027312 CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF |
| 02/03/2011 | US20110027306 TC-83-Derived Alphavirus Vectors, Particles and Methods |
| 02/03/2011 | US20110027304 Yersinia pestis antigens, vaccine compositions and related methods |
| 02/03/2011 | US20110027300 Identification of a novel cysteine-rich cell penetrating peptide |
| 02/03/2011 | US20110027299 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 02/03/2011 | US20110027294 Anti-Respiratory Syncytial Virus Antibodies, Antigens and Uses Thereof |
| 02/03/2011 | US20110027287 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9) |
| 02/03/2011 | US20110027279 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 02/03/2011 | US20110027270 Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| 02/03/2011 | US20110027267 Fusion Proteins of Mannose Binding Lectins for Treatment of Disease |
| 02/03/2011 | US20110027235 Targeted integration into stem cells |
| 02/03/2011 | US20110027182 Substance for obtaining highly effective tumor medications as well as a process |